Growing community of inventors

San Diego, CA, United States of America

Manouchehr Shahbaz

Average Co-Inventor Count = 5.33

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 46

Manouchehr ShahbazThomas George Gant (8 patents)Manouchehr ShahbazChengzhi Zhang (7 patents)Manouchehr ShahbazJohn Carter (7 patents)Manouchehr ShahbazJohn Charles Arthur (7 patents)Manouchehr ShahbazAndreas Sommer (7 patents)Manouchehr ShahbazMargaret Bradbury (7 patents)Manouchehr ShahbazManouchehr Shahbaz (8 patents)Thomas George GantThomas George Gant (30 patents)Chengzhi ZhangChengzhi Zhang (59 patents)John CarterJohn Carter (17 patents)John Charles ArthurJohn Charles Arthur (9 patents)Andreas SommerAndreas Sommer (9 patents)Margaret BradburyMargaret Bradbury (9 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Auspex Pharmaceuticals, Inc. (8 from 71 patents)


8 patents:

1. 11666566 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

2. 11033540 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

3. 9814708 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

4. 9550780 - Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

5. 9346800 - Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

6. 9296739 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

7. 9233959 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

8. 8227451 - Phenylacetic acid inhibitors of cyclooxygenase

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…